| C09DA08 |
Olmesartan medoxomil/ Hydrochlorothiazide |
C09DA08 Olmesartan medoxomil/ Hydrochlorothiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
40 mg/12,5 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
52.27 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-10654/21.10.2016; НСР-17719/10.01.2019 |
02.02.2019 |
|
|
Активен |
15454 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
20 mg/12,5 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
86.4 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-10654/21.10.2016 |
02.09.2018 |
|
|
Активен |
15453 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
20 mg/25 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
86.4 |
0.41783 |
12.53 |
50% |
6.26 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11681/10.02.2017 |
02.09.2018 |
|
|
Активен |
15599 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
40 mg/25 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
108 |
0.66816 |
20.04 |
50% |
10.02 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11681/10.02.2017 |
02.09.2018 |
|
|
Активен |
15600 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Neosara-Co |
Film coated tablet |
40 mg/12.5 mg |
|
30 |
МС Фарма АД, България |
1 |
tabl |
- |
38.51 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-17982/21.02.2019 |
02.04.2019 |
|
|
Активен |
16442 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Neosara-Co |
Film coated tablet |
20 mg/12.5 mg |
|
30 |
МС Фарма АД, България |
1 |
tabl |
- |
27.22 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-17982/21.02.2019 |
02.04.2019 |
|
|
Активен |
16443 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesartan/HCTZ Mylan |
Film coated tablet |
40 mg/12.5 mg |
|
30 |
Mylan Ireland Limited, Ирландия |
1 |
tabl |
- |
13.85 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13326/28.07.2017; НСР-16948/04.10.2018; НСР-18008/21.02.2019 |
02.04.2019 |
|
|
Активен |
15806 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesartan/HCTZ Mylan |
Film coated tablet |
20 mg/12.5 mg |
|
30 |
Mylan Ireland Limited, Ирландия |
1 |
tabl |
- |
13.85 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13326/28.07.2017; НСР-16950/04.10.2018; НСР-18007/21.02.2019 |
02.04.2019 |
|
|
Активен |
15805 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesartan/ Hydrochlorothiazide Aurobindo |
Film coated tablet |
40 mg/12,5 mg |
|
28 |
Aurobindo Pharma (Malta) Limited, Малта |
1 |
tabl |
- |
12.9 |
0.46071 |
12.9 |
50% |
6.45 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11679/10.02.2017; НСР-15656/17.05.2018 |
02.06.2018 |
|
|
Активен |
15597 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesta Plus |
Film coated tablet |
40 mg/ 12.5mg |
|
30 |
Тева Фармасютикълс България ЕООД, България |
1 |
tabl |
- |
13.85 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-2364/21.02.2012.; HCP-8621/31.03.2016.; НСР-12872/02.06.2017; НСР-16482/17.08.2018 |
02.09.2018 |
|
|
Активен |
1646 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesta Plus |
Film coated tablet |
20 mg/ 12.5mg |
|
30 |
Тева Фармасютикълс България ЕООД, България |
1 |
tabl |
- |
13.85 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-2363/21.02.2012 .; HCP-8621/31.03.2016.; НСР-12871/02.06.2017; НСР-16481/17.08.2018 |
02.09.2018 |
|
|
Активен |
1645 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmezide plus |
Film coated tablet |
20 mg/12,5 mg |
|
30 |
Stada Arzneimittel AG, Германия |
1 |
tabl |
- |
20.36 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11393/13.01.2017; НСР-17260/14.11.2018 |
02.12.2018 |
|
|
Активен |
15565 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmezide plus |
Film coated tablet |
40 mg/12,5 mg |
|
30 |
Stada Arzneimittel AG, Германия |
1 |
tabl |
- |
27.01 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11393/13.01.2017; НСР-17259/14.11.2018 |
02.12.2018 |
|
|
Активен |
15566 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Tansidor H |
Film coated tablet |
20 mg/12,5 mg |
|
30 |
Sandoz d.d., Словения |
1 |
tabl |
- |
17.81 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11049/01.12.2016; НСР-15110/26.02.2018 предварително изпълнение; НСР-18563/25.04.2019 |
02.06.2019 |
|
|
Активен |
15510 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Tansidor H |
Film coated tablet |
40 mg/12,5 mg |
|
30 |
Sandoz d.d., Словения |
1 |
tabl |
- |
19.52 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11049/01.12.2016; НСР-15109/26.02.2018 предварително изпълнение; НСР-18566/25.04.2019 |
02.06.2019 |
|
|
Активен |
15512 |
| C09DB01 |
Amlodipine/ Valsartan |
C09DB01 Amlodipine/ Valsartan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DB01 |
Amlodipine, Valsartan |
Amlodipine/Valsartan Mylan |
Film coated tablet |
10 mg/160 mg |
|
30 |
Mylan S.A.S., Франция |
1 |
tabl |
- |
18.42 |
0.30466 |
9.14 |
50% |
4.57 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13197/17.07.2017; НСР-16951/04.10.2018 |
02.11.2018 |
|
|
Активен |
15794 |
| C09DB01 |
Amlodipine, Valsartan |
Amlodipine/Valsartan Mylan |
Film coated tablet |
5 mg/160 mg |
|
30 |
Mylan S.A.S., Франция |
1 |
tabl |
- |
18.42 |
0.27783 |
8.33 |
50% |
4.17 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13197/17.07.2017 |
02.09.2017 |
|
|
Активен |
15793 |
| C09DB01 |
Amlodipine, Valsartan |
Amvalcon |
Film coated tablet |
5 mg/160 mg |
|
30 |
Фармаконс АД, България |
1 |
tabl |
- |
33.95 |
0.27783 |
8.33 |
50% |
4.16 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-15090/23.02.2018 |
02.04.2018 |
|
|
Активен |
16047 |
| C09DB01 |
Amlodipine, Valsartan |
Asbima |
Film coated tablet |
5 mg/160 mg |
|
30 |
Zentiva k.s., Чешка република |
1 |
tabl |
- |
32 |
0.27783 |
8.33 |
50% |
4.17 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-15403/04.04.2018 |
02.05.2018 |
|
|
Активен |
16085 |
| C09DB01 |
Amlodipine, Valsartan |
Asbima |
Film coated tablet |
10 mg/160 mg |
|
30 |
Zentiva k.s., Чешка република |
1 |
tabl |
- |
34.9 |
0.30466 |
9.14 |
50% |
4.57 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-15403/04.04.2018 |
02.05.2018 |
|
|
Активен |
16086 |
| C09DB01 |
Amlodipine, Valsartan |
Dipperam |
Film coated tablet |
5 mg/160 mg |
|
28 (PVC/PVDC блистери без перфорация) |
Sandoz d.d., Словения |
1 |
tabl |
- |
17.29 |
0.27783 |
7.78 |
50% |
3.89 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-15014/08.02.2018 |
02.03.2018 |
|
|
Активен |
16030 |
| C09DB01 |
Amlodipine, Valsartan |
Dipperam |
Film coated tablet |
10 mg/160 mg |
|
28 (PVC/PVDC блистери без перфорация) |
Sandoz d.d., Словения |
1 |
tabl |
- |
18.42 |
0.30466 |
8.53 |
50% |
4.26 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-15014/08.02.2018 |
02.03.2018 |
|
|
Активен |
16031 |
| C09DB01 |
Amlodipine, Valsartan |
Exforge |
Film coated tablet |
10 mg/160 mg |
mg |
28 |
Novartis Europharm Limited, Ирландия |
1 |
tabl |
- |
24.73 |
0.30466 |
8.53 |
50% |
4.26 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 164/ 20.04.2011; КЦРР-646/19.05.2012 г.; НСР-104/07.06.2013; НСР-2770/17.02.2014; НСР-4933/22.10.2014; НСР-9790/14.07.2016 г.; НСР-13882/25.09.2017; НСР-16610/24.08.2018; НСР-17323/22.11.2018 |
02.01.2019 |
08.09.2012 |
|
Активен |
3325 |